S.lab (soloways)
Clinical trials sponsored by S.lab (soloways), explained in plain language.
-
Experimental protein therapy tested for Hard-to-Treat inflammation
Disease control CompletedThis study tested an experimental protein therapy called GcMAF in adults with chronic inflammatory diseases like rheumatoid arthritis or chronic cystitis that didn't respond well to standard treatments. The two-part trial first checked the safety of different doses, then compared…
Phase: PHASE1, PHASE2 • Sponsor: S.LAB (SOLOWAYS) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test new shot to reprogram immune cells in arthritis
Disease control CompletedThis was an early-stage study to test the safety of a new drug called EF-M2 (Immutalon) for people with moderate-to-severe rheumatoid arthritis. The drug is designed to calm the immune system by changing the behavior of specific inflammatory cells. Forty-eight participants receiv…
Phase: PHASE1, PHASE2 • Sponsor: S.LAB (SOLOWAYS) • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New talk therapy aims to ease anxiety and depression
Symptom relief CompletedThis small pilot study tested a new type of group talk therapy called Terebenin's Method to see if it helps reduce symptoms of anxiety and depression. The therapy combines acting out scenarios, body awareness, and exploring family patterns over 8 weekly sessions. Researchers comp…
Phase: NA • Sponsor: S.LAB (SOLOWAYS) • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC